PRESS RELEASE published on 03/04/2026 at 07:30, 5 months 29 days ago Symrise delivered solid organic sales growth and strong profitability improvement for 2025 Symrise AG reported solid organic sales growth of 2.8% and improved profitability for 2025, with an adjusted EBITDA margin of 21.9%. Updated capital allocation priorities include a €400 million share buyback and 16th consecutive dividend increase Organic Sales Growth Dividend Increase Symrise AG Profitability Improvement 2025 Financial Results
PRESS RELEASE published on 03/04/2026 at 07:30, 5 months 29 days ago SIXT achieves record year 2025: Currency adjusted revenue increased by around 9% to EUR 4.3 billion – profit rises by almost 20% Sixt SE achieves record year 2025 with nearly 9% revenue growth to EUR 4.3 billion & 20% profit increase. Plans for continued growth in 2026 with expanded mobility platform Revenue Growth Record Year Profit Increase Sixt SE Mobility Platform
PRESS RELEASE published on 03/04/2026 at 07:03, 5 months 29 days ago EQS-Adhoc: adidas AG extends Bjørn Gulden’s contract as Chief Executive Officer and initiates transition at the helm of the Supervisory Board adidas AG extends Bjørn Gulden’s contract as Chief Executive Officer and initiates transition at the helm of the Supervisory Board. Key personnel decisions announced Supervisory Board Chief Executive Officer Personnel Decisions Adidas AG Bjørn Gulden
REGULATED PRESS RELEASE published on 03/04/2026 at 07:02, 5 months 29 days ago TERACT - Availibility of the Half-year Financial Report As of 31 December 2025 TERACT announces availability of its half-year financial report as of 31 December 2025, compliant with regulations, filed with AMF and accessible on company and AMF websites Financial Statements TERACT AMF Regulations Half-year Financial Report
REGULATED PRESS RELEASE published on 03/04/2026 at 07:02, 5 months 29 days ago TERACT - H1 2025-2026 results TERACT's H1 2025-2026 results impacted by store disposals amid sluggish market conditions. InVivo Group proposes public buy-out and squeeze-out of TERACT shares to support new roadmap TERACT Results Store Disposals InVivo Group H1 2025-2026
PRESS RELEASE published on 03/04/2026 at 07:00, 5 months 29 days ago Fourth quarter 2025 Results - EUR 208 million net income in Q4 2025, contributing to a strong full year net income of EUR 851 million - Proposed regular dividend of EUR 1.9 per share SCOR SE reports EUR 208 million net income in Q4 2025, contributing to a strong full year net income of EUR 851 million. Proposed regular dividend of EUR 1.9 per share approved by the Board Financial Results Net Income Dividend Scor SE Q4 2025
PRESS RELEASE published on 03/04/2026 at 07:00, 5 months 29 days ago BioVersys Announces Publication of BV100 Phase 1 Clinical Data in Journal of Antimicrobial Agents and Chemotherapy BioVersys announces publication of BV100 Phase 1 clinical data in Journal of Antimicrobial Agents and Chemotherapy Clinical Data Phase 1 BV100 BioVersys Antibacterial
PRESS RELEASE published on 03/04/2026 at 06:45, 5 months 29 days ago Anja Hendel, Max Müller and Peter Schmid von Linstow to be nominated to the Supervisory Board of Redcare Pharmacy. Anja Hendel, Max Müller and Peter Schmid von Linstow nominated to Redcare Pharmacy's Supervisory Board, enhancing expertise & strategic oversight. Björn Söder, Jérôme Cochet, Jaska de Bakker to step down Governance Supervisory Board Expertise Redcare Pharmacy Nominees
PRESS RELEASE published on 03/04/2026 at 06:44, 5 months 29 days ago PALFINGER AG – THIRD-BEST FISCAL YEAR IN THE COMPANY'S HISTORY AND FOCUS ON PROFITABLE GROWTH PALFINGER AG reports third-best fiscal year, with EUR 2.34 billion revenue, EUR 174.3 million EBIT, and focus on profitable growth. Strong balance sheet and global expansion strategies Global Expansion Financial Performance Profitable Growth Fiscal Year PALFINGER AG
PRESS RELEASE published on 03/04/2026 at 06:30, 5 months 29 days ago Redcare Pharmacy: Strong growth in 2025 surpassing EUR 1bn in Rx revenue; adj. EBITDA up 72% yoy. Redcare Pharmacy reports strong growth in 2025, surpassing EUR 1bn in Rx revenue with adj. EBITDA up 72% yoy. Active customers grow to 13.9M. Guidance for 2026: 13%-15% revenue growth, adj. EBITDA margin 2.5% Adjusted EBITDA Redcare Pharmacy 2025 Growth Rx Revenue 2026 Guidance
Published on 09/02/2026 at 18:45, 2 hours 2 minutes ago Full Circle Lithium Rebrands as FCL-X Fire & Safety Inc. and Provides Corporate Update
Published on 09/02/2026 at 15:00, 5 hours 47 minutes ago Vox Royalty Enters into Binding Agreement to Acquire the White Dam Gold Royalty in Australia
Published on 09/02/2026 at 14:30, 6 hours 17 minutes ago Solitario Completes Phase-One Drilling at Golden Crest - Reports Initial Drill Results for Ponderosa
Published on 09/02/2026 at 14:00, 6 hours 47 minutes ago Orogen Royalties Acquires Two Gold Projects in Southwest Utah
Published on 09/02/2026 at 14:00, 6 hours 47 minutes ago Datametrex Plans to Focus on AI, Data Centre, and Patent Licensing
Published on 09/02/2026 at 19:50, 56 minutes ago Cotecna Strengthens Food Testing Capabilities in India with Geo-Chem's New Food Safety Laboratory in Navi Mumbai, India
Published on 09/02/2026 at 18:48, 1 hour 58 minutes ago Original-Research: Rakovina Therapeutics Inc. (von First Berlin Equity Research GmbH): Add
Published on 09/02/2026 at 18:15, 2 hours 32 minutes ago Haier Smart Home Co., Ltd. Launches Voluntary Public Share Buy-back Offer for up to 81,044,512 D-Shares at EUR 1.87
Published on 09/02/2026 at 18:14, 2 hours 32 minutes ago Delivery Hero’s Management Board and Supervisory Board publish joint reasoned statement recommending shareholders to accept the takeover offer from Uber
Published on 09/02/2026 at 18:20, 2 hours 27 minutes ago Appointment to Edenred’s Executive Committee
Published on 09/02/2026 at 18:00, 2 hours 47 minutes ago Outstanding shares and voting rights statement at 31 August 2026
Published on 09/02/2026 at 17:45, 3 hours 2 minutes ago Disclosure of shares outstanding and voting rights - 02.09.2026
Published on 09/02/2026 at 17:35, 3 hours 12 minutes ago Derichebourg Environnement and Vicat strengthen their cooperation to support industrial decarbonisation and the circular economy through their VALèreCO joint venture
Published on 09/02/2026 at 07:43, 13 hours 3 minutes ago Accor launches an offering of bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2032 for a nominal amount of €380 million and a concurrent partial repurchase offer with respect to its outstanding OCEANEs due 2027 by